In-depth interpretation: Trastuzumab market pricing overview in Germany in 2024

Fam-trastuzumab deruxtecan-nxki (Fam-trastuzumab deruxtecan-nxki) is a cutting-edge anti-cancer injection specifically targeted at breast cancer that cannot be completely removed by surgery and has spread to other parts of the body. It also provides new treatment options for stomach cancer patients who experience recurrence after treatment, or whose cancer has metastasized to nearby tissues or other parts of the body. The drug is also being used in adults with certain types of non-small cell lung cancer that are also difficult to cure with surgery or that spread despite other treatments.

Detrastuzumab is an innovative anti-cancer injection that has begun to show its prominence in the domestic market. It is understood that the price of each box of 100mg of Detrastuzumab is about 10,000 yuan or more, which puts certain restrictions on its purchase in the domestic market. In Hong Kong, whether it is the regular version or the original version of trastuzumab, each box of the same 100mg price is about 15,000 yuan. Although prices may change due to exchange rate fluctuations, overall there is a certain price difference between the two.

Although there are price differences between trastuzumab in Hong Kong and China, their drug ingredients remain the same. This also shows that no matter which market it is in, trastuzumab maintains its unique efficacy and quality. Unfortunately, however, there is currently no generic version of trastuzumab on the market, which undoubtedly further exacerbates the difficulty for patients to obtain this drug. However, with the continuous advancement of medical technology and the gradual liberalization of policies, trastuzumab will bring new treatment options and hope to more patients.